US11723869 — Freeze-dried product and gas-filled microvesicles suspension
Method of Use · Assigned to Bracco Suisse SA · Expires 2039-05-15 · 13y remaining
What this patent protects
This patent protects a method of manufacturing a suspension of gas-filled microvesicles by reconstituting a freeze-dried product that has been thermally treated.
USPTO Abstract
A method of manufacturing a suspension of gas-filled microvesicles by reconstituting a freeze-dried product and a suspension obtained according to said method, where the freeze-dried product has been subjected to a thermal treatment.
Drugs covered by this patent
- sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3666 |
— | sulfur-hexafluoride-lipid-type-a-microspheres |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.